...
首页> 外文期刊>Oncology letters >Association between the MTHFR C677T polymorphism and gastric cancer susceptibility: A meta-analysis of 5,757 cases and 8,501 controls
【24h】

Association between the MTHFR C677T polymorphism and gastric cancer susceptibility: A meta-analysis of 5,757 cases and 8,501 controls

机译:MTHFR C677T基因多态性与胃癌易感性的关联:对5,757例病例和8,501例对照的荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Current data regarding the association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and the risk of developing gastric cancer are insufficient to draw definite conclusions. Therefore, the present meta-analysis was conducted to achieve a more precise estimation of the association. MEDLINE, EMBASE and Wanfang database searches resulted in the identification of 28 eligible studies describing 5,757 cases and 8,501 controls. The strength of the association between the MTHFR C677T polymorphism and gastric cancer risk were evaluated using crude odds ratios (ORs), with 95% confidence intervals (CIs). The pooled ORs were determined using homozygous (TT vs. CC), heterozygous (CT vs. CC), dominant (TT+CT vs. CC) and recessive (TT vs. CC+CT) models. When all studies were pooled into the metaanal-ysis, significant associations were identified between the MTHFR C677T polymorphism and the risk of gastric cancer (homozygous model: OR, 1.39; 95% CI, 1.20-1.62; heterozygous model: OR, 1.18; 95% CI, 1.05-1.32; dominant model: OR, 1.23; 95% CI, 1.10-1.38; recessive model: OR, 1.26; 95% CI, 1.12-1.42). Stratification of the data by ethnicity identified a statistically significantly elevated risk of gastric cancer in Asian MTHFR C677T polymorphism populations (homozygous model: OR, 1.64; 95% CI, 1.43-1.90; heterozygous model: OR, 1.30; 95% CI, 1.16-1.45; dominant model: OR, 1.39; 95% CI, 1.25-1.54; recessive model: OR, 1.41; 95% CI, 1.25-1.51), but not in Caucasian populations (homozygous model: OR, 1.15; 95% CI, 0.89-1.48; heterozygous model: OR, 1.03; 95% CI, 0.84-1.25; dominant model: OR, 1.05; 95% CI, 0.86-1.28; recessive model: OR, 1.09; 95% CI, 0.91-1.31). Following adjustment for heterogeneity, the current meta-analysis demonstrated that the MTHFR C677T polymorphism was not associated with the risk of gastric cancer in Caucasian individuals. Furthermore, no evidence of publication bias was observed. Thus, the current meta-analysis indicates that the MTHFR C677T allele may be a lowpenetrant risk factor for the development of gastric cancer in Asian populations.
机译:有关亚甲基四氢叶酸还原酶(MTHFR)C677T多态性与患胃癌风险之间关系的最新数据不足以得出明确的结论。因此,进行本荟萃分析以实现对关联的更精确估计。通过MEDLINE,EMBASE和Wanfang数据库搜索,鉴定了28项合格研究,描述了5,757例病例和8,501例对照。 MTHFR C677T多态性与胃癌风险之间的关联强度使用具有95%置信区间(CI)的原始比值比(OR)进行评估。合并的OR使用纯合(TT vs. CC),杂合(CT vs. CC),显性(TT + CT vs. CC)和隐性(TT vs. CC + CT)模型确定。将所有研究汇总到后肛门分解中后,MTHFR C677T多态性与胃癌风险之间存在显着相关性(纯合子模型:OR,1.39; 95%CI,1.20-1.62;杂合子模型:OR,1.18; 95 %CI,1.05-1.32;显性模型:OR,1.23; 95%CI,1.10-1.38;隐性模型:OR,1.26; 95%CI,1.12-1.42)。按种族对数据进行分层后,发现亚洲MTHFR C677T多态性人群的胃癌风险有统计学上的显着升高(纯合子模型:OR,1.64; 95%CI,1.43-1.90;杂合子模型:OR,1.30; 95%CI,1.16- 1.45;优势模型:OR,1.39; 95%CI,1.25-1.54;隐性模型:OR,1.41; 95%CI,1.25-1.51),但在高加索人群中则不是(纯合子模型:OR,1.15; 95%CI, 0.89-1.48;杂合模型:OR,1.03; 95%CI,0.84-1.25;显性模型:OR,1.05; 95%CI,0.86-1.28;隐性模型:OR,1.09; 95%CI,0.91-1.31)。在对异质性进行调整之后,当前的荟萃分析表明,MTHFR C677T多态性与白种人个体患胃癌的风险无关。此外,没有观察到发表偏见的证据。因此,目前的荟萃分析表明,MTHFR C677T等位基因可能是亚洲人群胃癌发展的低渗透危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号